Terrence Mccormick Email & Phone Number

BioPharma executive and advisor with a track record of success in R&D, product development and commercialization, and in extracting greater performance out of R&D investments. Known for cutting through the complexity of R&D to improve economic returns.As an "R&D Business Architect" I have pioneered a framework that leverages new techniques and technologies that reduces errors, costs, and time, delivers quantifiable results, and creates leapfrog advantages over competitors. With this framework, I am advising and guiding clients to huge value gains from their R&D efforts, such as: A novel R&D program expected to yield up to $4 billion in additional revenue, Rationalized portfolio of 2 merging pharmaceutical firms, increasing their joint pipeline by $1 billion, Positioned company for $60 million bottom-line growth despite 50% budget and staffing reductions.Visionary leader . . . able to quickly assess situations and orchestrate turnaround strategies, driving stability and growth.Innovative thinker . . . combines extensive knowledge of emerging technologies with exceptional problem-solving skills.EDUCATIONM.B.A., Executive Program, The Wharton School of Business, PA.Global Manager Development Program, London Business School.B.S. - Chemistry/Business, Yale University, CT.Specialties: R&D process and portfolio management, using six sigma and contstraint-based methods.Semantic integration creating R&D intelligence via unstructured information that identifies critical signals & ideas crucial to your R&D programs.Competitive intelligence – smarter, more nimble in-licensing capability and performance.Drug discovery and development – New tools for preclinical indication of likely drug-disease interactions Managing decentralized R&D organizations, teams and innovations

Listed skills include R&D, Life Sciences, Product Development, Portfolio Management, and 29 others.